Veliparib concomitant with first-line chemotherapy and as maintenance therapy in ovarian cancer: Final overall survival and disease-related symptoms results

Authors: Bookman, Michael A | European Journal Of Cancer (Oxford, England : 1990) | June 17, 2025 | PubMed abstract

Explore all publications

Back To Top